Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QBX258 in Breast Cancer Related Upper Extremity Lymphedema
NCT02494206Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2015
- Primary completion
- May 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Open-label trial of QBX258 in lymphedema, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Volume Changes as Measured by Perometry at 1 year. Started Jul 2015; status: completed.
02
Drugs
QBX258
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT02494206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494206.